3-hydroxybutyric acid has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 4 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dejgaard, A | 1 |
Andersen, P | 1 |
Hvidberg, A | 1 |
Hilsted, J | 1 |
Bottini, P | 1 |
Boschetti, E | 1 |
Pampanelli, S | 1 |
Ciofetta, M | 1 |
Del Sindaco, P | 1 |
Scionti, L | 1 |
Brunetti, P | 1 |
Bolli, GB | 1 |
Wahrenberg, H | 1 |
Arner, P | 1 |
Adamsson, U | 1 |
Lins, PE | 1 |
Juhlin-Dannfelt, A | 1 |
Ostman, J | 1 |
Scheen, AJ | 1 |
Gillet, J | 1 |
Rosenthaler, J | 1 |
Guiot, J | 1 |
Henrivaux, P | 1 |
Jandrain, B | 1 |
Lefèbvre, PJ | 1 |
4 other studies available for 3-hydroxybutyric acid and Asymmetric Diabetic Proximal Motor Neuropathy
Article | Year |
---|---|
Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy.
Topics: 3-Hydroxybutyric Acid; Adrenergic alpha-Agonists; Adult; Blood Glucose; Blood Pressure; Cardiac Outp | 1996 |
Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.
Topics: 3-Hydroxybutyric Acid; Autonomic Nervous System Diseases; Blood Glucose; Carbon Dioxide; Diabetes Me | 1997 |
Increased lipolytic sensitivity to catecholamines in diabetic patients with severe autonomic neuropathy.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adult; Autonomic Nervous System Diseases; Blood Glucose; Cate | 1990 |
Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Neuropat | 1989 |